Bioinova, as

Bioinova, as is a renowned Czech biotechnology company specializing in the research, development and production of cell therapies with a focus on mesenchymal stem cells. The company was established as a spin-off from research institutions and has since its foundation established itself as a key player in the field of modern therapy in the Czech Republic. It focuses primarily on therapeutic applications in orthopedics, neurology and dermatology, where it develops personalized medicinal products designed to regenerate damaged tissues, accelerate healing or alleviate inflammatory conditions.

Bioinova operates its own laboratories that meet the conditions of good manufacturing practice (GMP), holds a license from the Czech Medical Research Council (SÚKL) and participates in several clinical trials in the Czech Republic. An important part of its activities is the translation of scientific knowledge into practice - i.e. the direct connection of research with clinical use. The company closely cooperates with teaching hospitals, research institutes and universities, and actively participates in the development of new treatments and the validation of therapeutic protocols.

Thanks to its know-how, professional background and strong focus on quality and safety, Bioinova is one of the pioneers in the field of cell therapy in the Central European region.

Areas of activity

• Development and production of medicinal products based on mesenchymal stem cells

• Applications of cell therapies in orthopedics, neurology and dermatology

• Clinical trials and approval of products in the ATMP regime

• Translation of scientific knowledge into medical practice

• Collaboration with hospitals, research institutions and academia

Bioinova, as develops stem cell therapies for regenerative medicine and clinical use in orthopedics, neurology and dermatology.